Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Risk on sentiment helps lift FTSE and oil

Monday, 3rd December 2018
The G20 summit had two big bits of positive news for the market at the weekend and that is firing big gains for the FTSE 100 today. By midday the index was up nearly 2% at 7,116.66.

Most significantly the US and China agreed an effective ceasefire on their trade war, this is lifting resources stocks amid hopes the move will help support the commodity-consuming Chinese economy.

Talks between Saudi Arabia and Russia also brought the promise of a co-ordinated effort in the oil market, only slightly soured by news Qatar is quitting OPEC. The oil producers' cartel is set to meet in Vienna on Thursday.

Futures markets are pointing to big gains in the US when trading resumes in New York later on.


London Southend airport owner Stobart Group fell 10.5% to 176.9p after it decided to cut its dividend to conserve cash for investments in its aviation and energy divisions.

Plastic products manufacturer RPC Group fell 4.2% to 686.4p on news that a takeover pursuit of the company had become a one-horse race.

Bain Capital was no longer interested in a tie-up, RPC said, while an extension had been granted to Apollo Global Management to decide whether it wanted to lodge a firm bid.

AstraZeneca gained 1% to £61.76 as it completed a deal to sell rights to acid reflux and arthritis treatments to Grunenthal for a combined $815m.

Engineering services group Babcock International ticked up 0.6% to 571.6p on news that a joint venture with UGL had been awarded a new A$1.5bn (£866m) contract by the Australian Defence Force.

Spirax-Sarco Engineering gained 3.8% to £63.65 on announcing that it had sold German industrial air humidification equipment supplier HygroMatik to Carel Industries for €59.0m.

Power generation company Drax fell 1.1% to 386p despite favourably tweaking the terms of a deal to buy pumped storage, hydro and gas-fired generation assets from Spain's Iberdrola.


Convenience store retailer McColl's Retail tumbled 29.4% to 83.9p after it downgraded earnings expectations for both the year just-ended and the current financial year, citing supplier disruptions, higher labor costs and 'consumer uncertainty'.

Medical diagnostics kit supplier Omega Diagnostics shed 15.6% to 14.1p as it reported a rise in first-half profit that was entirely driven by asset-sale proceeds. Revenue from continuing operations slipped 7%.

Shield Therapeutics gained 0.6% to 34p on news that the US Food and Drug Administration had accepted for review a new drug application for its lead iron deficiency product.

Story provided by

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.